Clinical trial
Effect of 5 Years of GH Replacement on Atherosclerosis
NCT00462475 · Federico II University, Other · Completed
Key facts
| NCT number | NCT00462475 |
|---|---|
| Title | Effect of 5 Years of GH Replacement on Atherosclerosis |
| Official title | Phase 4 Study of Recombinant GH on Intima-Media Thickness at Common Carotids and on Cardiovascular Risk Factors in Hypopituitary Patients |
| Acronym | 5yrGH |
| Lead sponsor | Federico II University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypopituitarism, Pituitary Tumors, Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | Recombinant Growth Hormone, Genotropin (Pfizer) |
| Enrollment | 20 |
| Start date | Jan 1, 1996 |
| Completion | Dec 1, 2006 |
| First posted | Apr 19, 2007 |
| Last update posted | Oct 16, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: